Nkx2.5 marks angioblasts that contribute to hemogenic endothelium of the endocardium and dorsal aorta

  1. Lyad Zamir
  2. Reena Singh
  3. Elisha Nathan
  4. Ralph Patrick
  5. Oren Yifa
  6. Yfat Yahalom-Ronen
  7. Alaa A Arraf
  8. Thomas M Schultheiss
  9. Shengbao Suo
  10. Jing-Dong Jackie Han
  11. Guangdun Peng
  12. Naihe Jing
  13. Yuliang Wang
  14. Nathan Palpant
  15. Patrick PL Tam
  16. Richard P Harvey  Is a corresponding author
  17. Eldad Tzahor  Is a corresponding author
  1. Weizmann Institute of Science, Israel
  2. Victor Chang Cardiac Research Institute, Australia
  3. Technion-Israel Institute of Technology, Israel
  4. Chinese Academy of Sciences, China
  5. The University of Washington, United States
  6. The University of Queensland, Australia
  7. The University of Sydney, Australia

Abstract

Novel regenerative therapies may stem from deeper understanding of the mechanisms governing cardiovascular lineage diversification. Using enhancer mapping and live imaging in avian embryos, and genetic lineage tracing in mice, we investigated the spatio-temporal dynamics of cardiovascular progenitor populations. We show that expression of the cardiac transcription factor Nkx2.5 marks a mesodermal population outside of the cardiac crescent in the extraembryonic and lateral plate mesoderm, with characteristics of hemogenic angioblasts. Extra-cardiac Nkx2.5 lineage progenitors migrate into the embryo and contribute to clusters of CD41+/CD45+ and RUNX1+ cells in the endocardium, the aorta-gonad-mesonephros region of the dorsal aorta and liver. We also demonstrated that ectopic expression of Nkx2.5 in chick embryos activates the hemoangiogenic gene expression program. Taken together, we identified a hemogenic angioblast cell lineage characterized by transient Nkx2.5 expression that contributes to hemogenic endothelium and endocardium, suggesting a novel role for Nkx2.5 in hemoangiogenic lineage specification and diversification.

Data availability

The following previously published data sets were used

Article and author information

Author details

  1. Lyad Zamir

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  2. Reena Singh

    Victor Chang Cardiac Research Institute, Darlinghurst, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Elisha Nathan

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  4. Ralph Patrick

    Victor Chang Cardiac Research Institute, Darlinghurst, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Oren Yifa

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  6. Yfat Yahalom-Ronen

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    Competing interests
    The authors declare that no competing interests exist.
  7. Alaa A Arraf

    Department of Genetics and Developmental Biology, Technion-Israel Institute of Technology, Haifa, Israel
    Competing interests
    The authors declare that no competing interests exist.
  8. Thomas M Schultheiss

    Department of Genetics and Developmental Biology, Technion-Israel Institute of Technology, Haifa, Israel
    Competing interests
    The authors declare that no competing interests exist.
  9. Shengbao Suo

    Key Laboratory of Computational Biology, Chinese Academy of Sciences, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Jing-Dong Jackie Han

    Key Laboratory of Computational Biology, Chinese Academy of Sciences, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Guangdun Peng

    State Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Naihe Jing

    State Key Laboratory of Cell Biology, Chinese Academy of Sciences, Shanghai, China
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1509-6378
  13. Yuliang Wang

    Institute for Stem Cell and Regenerative Medicine, The University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Nathan Palpant

    Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Australia
    Competing interests
    The authors declare that no competing interests exist.
  15. Patrick PL Tam

    Embryology Unit, Children's Medical Research Institute, The University of Sydney, Westmead, Australia
    Competing interests
    The authors declare that no competing interests exist.
  16. Richard P Harvey

    Victor Chang Cardiac Research Institute, Darlinghurst, Australia
    For correspondence
    r.harvey@victorchang.edu.au
    Competing interests
    The authors declare that no competing interests exist.
  17. Eldad Tzahor

    Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
    For correspondence
    eldad.tzahor@weizmann.ac.il
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5212-9426

Funding

Israel Science Foundation

  • Lyad Zamir
  • Elisha Nathan
  • Oren Yifa
  • Eldad Tzahor

National Health and Medical Research Council (1074386,573732,1110751)

  • Reena Singh
  • Ralph Patrick
  • Patrick PL Tam
  • Richard P Harvey

Stem Cells Australia (SR110001002)

  • Reena Singh
  • Ralph Patrick
  • Richard P Harvey

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Kari Alitalo, University of Helsinki, Finland

Ethics

Animal experimentation: Mice used in this study were bred and maintained in the Victor Chang Cardiac Research Institute BioCore facility according to the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.Use of chick embryos before embryonic Day 21 does not require IACUC approval.

Version history

  1. Received: August 26, 2016
  2. Accepted: March 6, 2017
  3. Accepted Manuscript published: March 8, 2017 (version 1)
  4. Version of Record published: April 21, 2017 (version 2)

Copyright

© 2017, Zamir et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,080
    views
  • 689
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lyad Zamir
  2. Reena Singh
  3. Elisha Nathan
  4. Ralph Patrick
  5. Oren Yifa
  6. Yfat Yahalom-Ronen
  7. Alaa A Arraf
  8. Thomas M Schultheiss
  9. Shengbao Suo
  10. Jing-Dong Jackie Han
  11. Guangdun Peng
  12. Naihe Jing
  13. Yuliang Wang
  14. Nathan Palpant
  15. Patrick PL Tam
  16. Richard P Harvey
  17. Eldad Tzahor
(2017)
Nkx2.5 marks angioblasts that contribute to hemogenic endothelium of the endocardium and dorsal aorta
eLife 6:e20994.
https://doi.org/10.7554/eLife.20994

Share this article

https://doi.org/10.7554/eLife.20994

Further reading

    1. Developmental Biology
    Yongfeng Luo, Ke Cao ... Wei Shi
    Research Article

    Abnormal lung development can cause congenital pulmonary cysts, the mechanisms of which remain largely unknown. Although the cystic lesions are believed to result directly from disrupted airway epithelial cell growth, the extent to which developmental defects in lung mesenchymal cells contribute to abnormal airway epithelial cell growth and subsequent cystic lesions has not been thoroughly examined. In the present study using genetic mouse models, we dissected the roles of bone morphogenetic protein (BMP) receptor 1a (Bmpr1a)-mediated BMP signaling in lung mesenchyme during prenatal lung development and discovered that abrogation of mesenchymal Bmpr1a disrupted normal lung branching morphogenesis, leading to the formation of prenatal pulmonary cystic lesions. Severe deficiency of airway smooth muscle cells and subepithelial elastin fibers were found in the cystic airways of the mesenchymal Bmpr1a knockout lungs. In addition, ectopic mesenchymal expression of BMP ligands and airway epithelial perturbation of the Sox2-Sox9 proximal-distal axis were detected in the mesenchymal Bmpr1a knockout lungs. However, deletion of Smad1/5, two major BMP signaling downstream effectors, from the lung mesenchyme did not phenocopy the cystic abnormalities observed in the mesenchymal Bmpr1a knockout lungs, suggesting that a Smad-independent mechanism contributes to prenatal pulmonary cystic lesions. These findings reveal for the first time the role of mesenchymal BMP signaling in lung development and a potential pathogenic mechanism underlying congenital pulmonary cysts.

    1. Developmental Biology
    Youjia Guo, Tomohiro Kitano ... Haruhiko Siomi
    Research Article

    Once fertilized, mouse zygotes rapidly proceed to zygotic genome activation (ZGA), during which long terminal repeats (LTRs) of murine endogenous retroviruses with leucine tRNA primer (MERVL) are activated by a conserved homeodomain-containing transcription factor, DUX. However, Dux-knockout embryos produce fertile mice, suggesting that ZGA is redundantly driven by an unknown factor(s). Here we present multiple lines of evidence that the multicopy homeobox gene, Obox4, encodes a transcription factor that is highly expressed in mouse 2-cell embryos and redundantly drives ZGA. Genome-wide profiling revealed that OBOX4 specifically binds and activates MERVL LTRs as well as a subset of murine endogenous retroviruses with lysine tRNA primer (MERVK) LTRs. Depletion of Obox4 is tolerated by embryogenesis, whereas concomitant Obox4/Dux depletion markedly compromises embryonic development. Our study identified OBOX4 as a transcription factor that provides genetic redundancy to pre-implantation development.